IP Library Granted Patent US 9,925,335
Granted Patent B2
US 9,925,335 · App. 15/035,132 · Granted Mar 27, 2018

Portable drug mixing and delivery device and associated methods

Inventors: Cole Constantineau (Cambridge, MA); Christopher J. Stepanian (Somerville, MA); Adam R. Standley (Cambridge, MA); Michel Bruehwiler (Newton, MA); Brent Buchine (Austin, TX); Jeffrey Thomas Chagnon (Somerville, MA); Robert Brik (Cambridge, MA)
A61M5/19A61M5/2033A61M5/2046A61M5/31596A61M5/3204A61M39/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,925,335
App. No.
15/035,132
Granted
Mar 27, 2018
Kind
B2
Abstract

A portable auto-injector configured to store a liquid component in a first chamber separately from a dry medication in a second chamber, wherein a first actuation mechanism opens a valve allowing for the initiation of a mixing step prior to injection. An extendable needle guard is provided over the delivery assembly which prevents premature injection as well as inadvertent sticks or other cross contamination of a needle. The needle guard can also form part of a secondary trigger mechanism which injects the mixed components after the mixing stage is complete.

Claims (11)

1. A medication mixing and delivery device, the device comprising:

a housing;

a first chamber located within the housing, the first chamber containing a first medicament component;

a second chamber located within the housing, the second chamber configured to selectively receive the first medicament component from the first chamber;

a valve located within the housing, the valve configured to provide selective fluidic communication between the first chamber and the second chamber;

a first displacement mechanism configured to reduce an effective volume of the first chamber and axially translate the second chamber with respect to the first chamber during a first actuation, wherein the first displacement mechanism is comprised of at least one radial protrusion configured to engage a channel formed in an intermediate support that is disposed in the housing, wherein the channel has a first portion, a second portion, and an intermediate stop disposed between the first and the second portions;

a second displacement mechanism configured to reduce an effective volume of the second chamber;

a second medicament component stored within the housing and outside the first chamber;

a second trigger which is mechanically coupled to the at least one radial protrusion, wherein triggering the second trigger causes the at least one radial protrusion to engage with the second portion of the channel;

wherein an actuation device is in mechanical communication with the valve, the actuation device being configured to change the valve between a closed state and an open state during the first actuation; and

wherein the first actuation moves the at least one radial protrusion relative to the first portion of the channel.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2025
From: WINDGAP MEDICAL, INC.
To: WINDGAPLEGACYCO, LLC
Reel/Frame 071907/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2018
From: STANDLEY, ADAM; BUCHINE, BRENT ALAN; STEPANIAN, CHRISTOPHER; CONSTANTINEAU, COLE; BRUEHWILER, MICHEL; BRIK, ROBERT; CHAGNON, JEFFREY THOMAS
To: WINDGAP MEDICAL, INC
Reel/Frame 044514/0908 →
Continuity (6)
Provisional Application 62038386 · Aug 18, 2014
Provisional Application 62126011 · Feb 27, 2015
Provisional Application 62061664 · Aug 10, 2014
Provisional Application 62120792 · Feb 25, 2015
Provisional Application 62204940 · Aug 13, 2015
Related Publication 20160263320A1 · Sep 15, 2016